RenovoRx, Inc. (RNXT) - Latest Market Data

Price & Market Data

Price: $0.865

Daily Change: +$0.0145 / 1.68%

Daily Range: $0.835 - $0.886

Market Cap: $39,322,000

Daily Volume: 126,689

Performance Metrics

1 Week: -5.98%

1 Month: -14.43%

3 Months: -11.84%

6 Months: -9.23%

1 Year: -17.66%

YTD: 3.89%

About RenovoRx, Inc. (RNXT)

Get the latest on RenovoRx, Inc. (RNXT). Priced at 0.865, with a daily shift of +$0.0145 / 1.68%. Market cap: 39,322,000. Crucial performance data includes YTD (3.89%) and 1-month (-14.43%) returns.

Company Details

Employees: 17

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

RenovoRx, Inc., a clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is chemotherapy gemcitabine, which is provided through RenovoCath that is in Phase III clinical trials for the treatment of locally advanced pancreatic cancer. RenovoRx, Inc. was founded in 2009 and is headquartered in Mountain View, California.

Selected stocks

Inno Holdings Inc. (INHD)

Eastern Bankshares, Inc. (EBC)

Cherry Hill Mortgage Investment Corporation (CHMI)

SoFi Technologies, Inc. (SOFI)